2.06
price down icon8.85%   -0.20
after-market Handel nachbörslich: 2.06
loading
Schlusskurs vom Vortag:
$2.26
Offen:
$2.26
24-Stunden-Volumen:
129.31K
Relative Volume:
0.83
Marktkapitalisierung:
$72.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-17.78M
KGV:
-3.7509
EPS:
-0.5492
Netto-Cashflow:
$-10.52M
1W Leistung:
+3.78%
1M Leistung:
-14.52%
6M Leistung:
-58.22%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$2.05
$2.28
1-Wochen-Bereich:
Value
$1.97
$2.335
52-Wochen-Spanne:
Value
$1.0779
$55.00

Fibrobiologics Inc Stock (FBLG) Company Profile

Name
Firmenname
Fibrobiologics Inc
Name
Telefon
281-671-5150
Name
Adresse
455 E. MEDICAL CENTER BLVD, HOUSTON
Name
Mitarbeiter
8
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
FBLG's Discussions on Twitter

Vergleichen Sie FBLG mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
FBLG
Fibrobiologics Inc
2.06 72.28M 0 -17.78M -10.52M -0.5492
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.11 106.13B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
733.59 80.61B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
649.26 38.82B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
240.55 31.03B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
122.15 29.28B 3.30B -501.07M 1.03B -2.1146

Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-12 Eingeleitet Rodman & Renshaw Buy
2024-10-30 Eingeleitet H.C. Wainwright Buy
2024-09-24 Eingeleitet Maxim Group Buy

Fibrobiologics Inc Aktie (FBLG) Neueste Nachrichten

pulisher
Jan 09, 2025

Geode Capital Management LLC Acquires 284,047 Shares of FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Jan 09, 2025
pulisher
Jan 09, 2025

Barclays PLC Buys 31,331 Shares of FibroBiologics, Inc. (NASDAQ:FBLG) - Defense World

Jan 09, 2025
pulisher
Jan 03, 2025

FibroBiologics, Inc. (NASDAQ:FBLG) Shares Bought by State Street Corp - Defense World

Jan 03, 2025
pulisher
Jan 01, 2025

FibroBiologics Secures Second Tranche of $5 Million Financing - Defense World

Jan 01, 2025
pulisher
Dec 31, 2024

FibroBiologics Announces $25 Million Financing - citybiz

Dec 31, 2024
pulisher
Dec 30, 2024

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing - GlobeNewswire

Dec 30, 2024
pulisher
Dec 30, 2024

FibroBiologics Secures Second $5M Tranche of $25M Equity Purchase Agreement with Yorkville Advisors - StockTitan

Dec 30, 2024
pulisher
Dec 30, 2024

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing - The Manila Times

Dec 30, 2024
pulisher
Dec 30, 2024

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing - GlobeNewswire Inc.

Dec 30, 2024
pulisher
Dec 28, 2024

FibroBiologics (NASDAQ:FBLG) Receives Buy Rating from D. Boral Capital - Defense World

Dec 28, 2024
pulisher
Dec 27, 2024

D. Boral Capital Reiterates Buy Rating for FibroBiologics (NASDAQ:FBLG) - MarketBeat

Dec 27, 2024
pulisher
Dec 25, 2024

**FibroBiologics Enters Standby Equity Purchase Agreement for $25 Million Financing** ** - Defense World

Dec 25, 2024
pulisher
Dec 24, 2024

FibroBiologics announces $25 million financing - MSN

Dec 24, 2024
pulisher
Dec 23, 2024

FibroBiologics, Inc. announced that it expects to receive $15 million in funding from Yorkville Advisors Global LP - Marketscreener.com

Dec 23, 2024
pulisher
Dec 23, 2024

FibroBiologics secures $25 million equity deal with Yorkville - Investing.com

Dec 23, 2024
pulisher
Dec 23, 2024

FibroBiologics Secures $25M Equity Agreement for Trials - TipRanks

Dec 23, 2024
pulisher
Dec 23, 2024

FibroBiologics Secures $25M Financing Deal to Advance Clinical Trials in Diabetic Foot Ulcers, Psoriasis - StockTitan

Dec 23, 2024
pulisher
Dec 22, 2024

FibroBiologics finalizes agreement and terminates warrant By Investing.com - Investing.com Canada

Dec 22, 2024
pulisher
Dec 22, 2024

FibroBiologics finalizes agreement and terminates warrant - Investing.com

Dec 22, 2024
pulisher
Dec 22, 2024

Ionq Inc (IONQ-N) QuotePress Release - The Globe and Mail

Dec 22, 2024
pulisher
Dec 17, 2024

FibroBiologics, Inc. (NASDAQ:FBLG) Short Interest Update - MarketBeat

Dec 17, 2024
pulisher
Dec 13, 2024

Rodman & Renshaw Initiates Coverage of FibroBiologics (FBLG) with Buy Recommendation - MSN

Dec 13, 2024
pulisher
Dec 12, 2024

FibroBiologics (NASDAQ:FBLG) Coverage Initiated at Rodman & Renshaw - MarketBeat

Dec 12, 2024
pulisher
Dec 03, 2024

FibroBiologics, Inc. (NASDAQ:FBLG) Short Interest Up 7.2% in November - MarketBeat

Dec 03, 2024
pulisher
Nov 21, 2024

FBLG: On Target to Initiate Phase 1/2 Trial in 2025… - MSN

Nov 21, 2024
pulisher
Nov 20, 2024

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly - GlobeNewswire

Nov 20, 2024
pulisher
Nov 20, 2024

FibroBiologics seeks patent for spleen disorder treatment By Investing.com - Investing.com Australia

Nov 20, 2024
pulisher
Nov 19, 2024

FibroBiologics seeks patent for spleen disorder treatment - Investing.com India

Nov 19, 2024
pulisher
Nov 19, 2024

FibroBiologics Files Patent for Breakthrough Splenomegaly Cell Therapy Treatment | FBLG Stock News - StockTitan

Nov 19, 2024
pulisher
Nov 15, 2024

HC Wainwright Expects Stronger Earnings for FibroBiologics - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

HC Wainwright Reaffirms Buy Rating for FibroBiologics (NASDAQ:FBLG) - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Fibrobiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction in Cell-Based Therapeutics - Marketscreener.com

Nov 14, 2024
pulisher
Nov 14, 2024

FibroBiologics files patent for reducing cell therapy risks - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

FibroBiologics seeks patent for clot-prevention method - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics - GlobeNewswire

Nov 14, 2024
pulisher
Nov 14, 2024

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with ... - The Bakersfield Californian

Nov 14, 2024
pulisher
Nov 14, 2024

FibroBiologics Files Patent for Breakthrough Cell Therapy Blood Clotting Prevention | FBLG Stock News - StockTitan

Nov 14, 2024
pulisher
Nov 14, 2024

Is FibroBiologics (NASDAQ:FBLG) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Nov 14, 2024
pulisher
Nov 14, 2024

FibroBiologics files patent for reducing cell therapy risks By Investing.com - Investing.com Nigeria

Nov 14, 2024
pulisher
Nov 13, 2024

FibroBiologics' (FBLG) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

FibroBiologics Reports Wider Q3 Loss, Advances Clinical Pipeline Amid R&D Push | FBLG Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

FibroBiologics Inc. (FBLG) Quarterly 10-Q Report - Quartz

Nov 12, 2024
pulisher
Nov 09, 2024

FBLGFibroBiologics, Inc. Latest Stock News & Market Updates - StockTitan

Nov 09, 2024
pulisher
Nov 03, 2024

HC Wainwright Begins Coverage on FibroBiologics (NASDAQ:FBLG) - Defense World

Nov 03, 2024
pulisher
Nov 01, 2024

HC Wainwright Forecasts FibroBiologics Q3 Earnings - MarketBeat

Nov 01, 2024
pulisher
Oct 31, 2024

H.C. Wainwright sets stock target on FibroBiologics shares, cites portfolio By Investing.com - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

FibroBiologics (NASDAQ:FBLG) Coverage Initiated by Analysts at HC Wainwright - MarketBeat

Oct 30, 2024
pulisher
Oct 30, 2024

FibroBiologics names interim CFO as Mark Andersen steps down By Investing.com - Investing.com Australia

Oct 30, 2024
pulisher
Oct 30, 2024

This NANO Nuclear Energy Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Wednesday - Benzinga

Oct 30, 2024
pulisher
Oct 29, 2024

FibroBiologics CFO Andersen Resigns - MarketWatch

Oct 29, 2024

Finanzdaten der Fibrobiologics Inc-Aktie (FBLG)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$73.13
price down icon 0.08%
$22.19
price up icon 0.05%
$366.61
price up icon 1.18%
$43.17
price down icon 9.17%
biotechnology ONC
$177.88
price up icon 1.59%
$122.15
price down icon 3.73%
Kapitalisierung:     |  Volumen (24h):